Tag: Israel
-
Calif. Agency Supporting Late Stem Cell Trial for ALS
California’s agency supporting stem cell research for regenerative medicine is helping fund a clinical trial testing stem cell treatments for amyotrophic lateral sclerosis, or ALS.
-
Exosuit Prototype Unveiled for Stroke Survivors
An assistive device with sensors and motors designed to help people with stroke and other muscle disorders walk more normally was demonstrated on 16 June.
-
Cancer Center to Test Focused Radiation Therapy
MD Anderson Cancer Center is testing new radiation treatments for cancer designed to reduce adverse side effects of conventional radiation therapy.
-
Laser-Produced Graphene Kills Resistant Bacteria
A materials science and engineering team found a form of graphene produced by lasers can kill films of bacteria resistant to treatment, aided by a weak electric current.
-
Mobile App-Controlled Patch Reduces Migraine Pain
A patch worn on the arm providing stimulation to nerve cells was shown in a clinical trial to reduce the amount of pain experienced by people with migraines.
-
Trial Begins Testing Enhanced Cord Blood Stem Cells
A clinical trial testing transplant grafts derived from umbilical cord blood as an alternative to bone marrow stem cells for people with blood-related cancers is treating its first patient.
-
Smart Watch Software Designed to Verify Signatures
Engineering researchers in Israel created software that enables smart watches and fitness bands to capture wrist movements for verifying a person’s signature.
-
Precision Health Tech Network Expands, Invests $400M
Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network.
-
Crowdfunded Digital Health Investment Fund Launches
An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies.
-
Teva Licenses Pain Relief Antibody for $1.25 Billion
Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals.